电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CCL2 抗体 (AA 102-130)

This anti-CCL2 antibody is a 大鼠 单克隆 antibody detecting CCL2 in WB, IHC (p) 和 IHC (fro). Suitable for 小鼠.
产品编号 ABIN1108186
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for CCL2 抗体 (AA 102-130) (ABIN1108186)

抗原

See all CCL2 抗体
CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

适用

  • 113
  • 61
  • 57
  • 24
  • 17
  • 16
  • 15
  • 9
  • 3
  • 3
  • 1
小鼠

宿主

  • 121
  • 64
  • 10
  • 7
  • 5
  • 2
  • 2
  • 2
  • 1
大鼠

克隆类型

  • 138
  • 76
单克隆

标记

  • 118
  • 28
  • 17
  • 7
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This CCL2 antibody is un-conjugated

应用范围

  • 145
  • 70
  • 66
  • 32
  • 30
  • 25
  • 24
  • 18
  • 15
  • 14
  • 14
  • 13
  • 11
  • 11
  • 10
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

克隆位点

ECE-2
  • 抗原表位

    • 22
    • 15
    • 13
    • 12
    • 8
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 102-130

    特异性

    The monoclonal antibody ECE.2 recognizes mouse monocyte chemoattractant protein 1 (MCP-1).

    无交叉反应

    交叉反应 (详细)

    Species reactivity (tested):Mouse.

    纯化方法

    Protein G Chromatography

    免疫原

    Synthetic peptide corresponding to residues 102-130 of Mouse MCP-1

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 浓度

    0.1 mg/mL

    缓冲液

    PBS, 0.02 % Sodium Azide, 0.1 % BSA

    储存液

    Sodium azide

    注意事项

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C

    储存方法

    Store undiluted at 2-8 °C.
  • 抗原

    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

    别名

    MCP1 / CCL2

    背景

    The murine JE gene encodes the monocyte-specific cytokine monocyte chemotactic protein 1 (MCP-1). MCP-1 is a CC chemokine of 76 amino acids (~11 kDa) and is chemotactic for monocytes and basophils but not neutrophils and eosinophils. MCP-1 is expressed by smooth muscle cells (SMC), macrophages, endothelial cells, keratinocytes and fibroblasts in response to inflammatory stimuli such as interleukin 1β and tumor necrosis factor α. MCP-1 has been implicated in a variety of inflammatory processes, including inflammatory bowel disease, rheumatoid arthritis, asthma, nephritis, and parasitic and viral infections. MCP-1 antigen is not detected in the endothelium or SMC of normal arteries. MCP-1 has also been shown to exhibit biological activities other than chemotaxis. It can induce the proliferation and activation of killer cells known as CHAK (CC-Chemokine-activated killer) MCP-1 signals via the CCR2 receptor, and is critical for aneurysm formation because of its stability to recruit leukocytes. These leukocytes produce extracellular matrix-degrading MMPs, thereby inductin aortic remodelling and dilatation. Interleukin-6 is also involved in this amplification loop accelerating vascular inflammation. MCP-/- mice display significantly delayed wound re-epithelialization, and also delayed wound angiogenesis.Synonyms: C-C motif chemokine 2, HC-11, HC11, MCAF, MCP-1, Monocyte chemoattractant protein 1, Monocyte chemotactic and activating factor, Monocyte chemotactic protein 1, Monocyte secretory protein JE, SCYA2, Small-inducible cytokine A2

    基因ID

    20296

    NCBI登录号

    NP_035463

    UniProt

    P10148

    途径

    Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here: